Literature DB >> 9077495

Expression of tumor necrosis factor-alpha in muscles of polymyositis.

M Tateyama1, I Nagano, M Yoshioka, K Chida, S Nakamura, Y Itoyama.   

Abstract

We immunohistochemically examined biopsied muscles from nine untreated patients with polymyositis (PM) and five patients with other neuromuscular diseases (ONMD), using monoclonal antibodies to tumor necrosis factor-alpha (TNF-alpha) and lymphoid surface markers. In muscles of three patients with PM, we observed many TNF-alpha positive macrophages and lymphocytes in endomysium and around vessels in the muscles. By contrast, there were few, weakly TNF-alpha stained cells in muscles of three patients with ONMD. The ratio of TNF-alpha-positive cells to the muscle fibers and the ratio of TNF-alpha-positive cells to the mononuclear cells were significantly higher in PM compared with ONMD. In addition, we observed atrophic muscle fibers more frequently in TNF-alpha-positive muscles than TNF-alpha-negative ones. We conclude that, at least, in a part of PM patients, TNF-alpha produced locally may contribute to the pathogenesis of PM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077495     DOI: 10.1016/s0022-510x(96)00280-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

Review 2.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 3.  Pathogenesis, classification and treatment of inflammatory myopathies.

Authors:  Mei Zong; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2011-04-05       Impact factor: 20.543

Review 4.  The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  I E Lundberg
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

Review 5.  The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

6.  Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.

Authors:  P Efthimiou; S Schwartzman; L J Kagen
Journal:  Ann Rheum Dis       Date:  2006-02-13       Impact factor: 19.103

7.  Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.

Authors:  Geun-Tae Kim; Mi-La Cho; Young-Eun Park; Wan Hee Yoo; Jung-Hee Kim; Hye-Jwa Oh; Dae-Sung Kim; Seung-Hoon Baek; Sun-Hee Lee; Jun-Hee Lee; Ho-Youn Kim; Sung-Il Kim
Journal:  Clin Rheumatol       Date:  2009-12-02       Impact factor: 2.980

8.  Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness.

Authors:  Sree Rayavarapu; William Coley; Travis B Kinder; Kanneboyina Nagaraju
Journal:  Skelet Muscle       Date:  2013-06-07       Impact factor: 4.912

9.  Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis.

Authors:  Kyoung-Hwa Choi; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2008-09-16       Impact factor: 3.580

Review 10.  Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases.

Authors:  Joachim R Kalden
Journal:  Arthritis Res       Date:  2002-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.